Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Nunzio Restuccia
Concomitant and Feasible Treatment With Dasatinib and the Anti-Egfr Antibody Cetuximab Plus Radiotherapy in a CML Patient With Multiple Squamous Neoplasias
Acta Oncologica
Nuclear Medicine
Radiology
Hematology
Oncology
Medicine
Imaging
Related publications
Place in Concomitant Use With Anti-Egfr Radiotherapy in Locally Advanced Head and Neck Cancer Treatment
Meandros Medical and Dental Journal
Dasatinib Worsens the Effect of Cetuximab in Combination With Fractionated Radiotherapy in FaDu- And A431-Derived Xenografted Tumours
British Journal of Cancer
Cancer Research
Oncology
Aberrant HER3 Ligand Heregulin-Expressing Head and Neck Squamous Cell Carcinoma Is Resistant to Anti-Egfr Antibody Cetuximab, but Not Second-Generation EGFR-TKI
Oncogenesis
Cancer Research
Molecular Biology
GC1118, a Novel Anti-Egfr Antibody, Has Potent KRAS Mutation-Independent Antitumor Activity Compared With Cetuximab in Gastric Cancer
Gastric Cancer
Cancer Research
Medicine
Oncology
Gastroenterology
EGFR Monoclonal Antibodies in the Treatment of Squamous Cell Carcinoma of the Head and Neck: A View Beyond Cetuximab
Chemotherapy Research and Practice
Cetuximab PET Delineated Changes in Cellular Distribution of EGFR Upon Dasatinib Treatment in Triple Negative Breast Cancer
Breast Cancer Research
Cancer Research
Oncology
A Novel Anti-Egfr mAb Ame55 With Lower Toxicity and Better Efficacy Than Cetuximab When Combined With Irinotecan
Journal of Immunology Research
Medicine
Allergy
Immunology
Phase 1 Study of EGFR-antisense DNA, Cetuximab, and Radiotherapy in Head and Neck Cancer With Preclinical Correlatives
Cancer
Cancer Research
Oncology
Combination Treatment With Hypofractionated Radiotherapy Plus IL-2/anti-IL-2 Complexes and Its Theranostic Evaluation
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
